Halozyme Therapeutics Inc (NASDAQ:HALO)

23.95
BATS BZX Real-Time Price
As of 2:24pm ET
 +1.15 / +5.04%
Today’s Change
7.51
Today|||52-Week Range
25.25
+148.19%
Year-to-Date

Today’s Trading

Previous close22.80
Today’s open22.99
Day’s range22.76 - 24.30
Volume867,201
Average volume (3 months)1,368,554
Market cap$2.9B
Dividend yield--
Data as of 2:08pm ET, 07/28/2015

Growth & Valuation

Earnings growth (last year)+24.32%
Earnings growth (this year)+14.20%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.47%
P/E ratioNM
Price/Sales15.72
Price/Book69.32

Competitors

 Today’s
change
Today’s
% change
KITEKite Pharma Inc+3.08+4.47%
RDUSRadius Health Inc-0.01-0.01%
NVAXNovavax Inc+0.59+5.03%
OPHTOphthotech Corp+1.90+2.86%
Data as of 2:24pm ET, 07/28/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$75.3M
Annual profit (last year)-$68.4M
Net profit margin-90.76%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers